Argent Advisors, Inc. Amgen Inc Transaction History

Argent Advisors, Inc.

$267 Million
Q3 2024

A detailed history of Argent Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Argent Advisors, Inc. holds 4,125 shares of AMGN stock, worth $1.08 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

4,125

Previous 4,094 0.76%

Holding current value

$1.08 Million

Previous $1.28 Million 3.91%

% of portfolio

0.5%

Previous 0.51%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $9,590 - $10,458	31 Added 0.76%	4,125 $1.33 Million
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $68,840 - $83,659	262 Added 6.84%	4,094 $1.28 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $36,028 - $43,491	134 Added 3.62%	3,832 $1.09 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $2,045 - $2,307	8 Added 0.22%	3,698 $1.07 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $59,910 - $74,380	274 Added 8.02%	3,690 $991,000
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $14,998 - $17,735	70 Added 2.09%	3,416 $758,000
Q1 2023 Apr 21, 2023	BUY	$225.79 - $275.2 $35,223 - $42,931	156 Added 4.89%	3,346 $808,000
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $32,751 - $41,614	143 Added 4.69%	3,190 $837,000
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $27,608 - $31,137	123 Added 4.21%	3,047 $687,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $20,763 - $23,106	90 Added 3.18%	2,924 $711,000
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $532,168 - $588,717	-2,427 Reduced 46.13%	2,834 $685,000
Q4 2021 Feb 02, 2022	BUY	$198.88 - $227.6 $105,804 - $121,083	532 Added 11.25%	5,261 $1.18 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $185,948 - $217,861	876 Added 22.74%	4,729 $1.01 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $111,651 - $123,868	478 Added 14.16%	3,853 $939,000
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $228,567 - $266,358	-1,030 Reduced 23.38%	3,375 $840,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $81,142 - $96,626	375 Added 9.31%	4,405 $1.01 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $3,989 - $4,436	17 Added 0.42%	4,030 $1.02 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $542,592 - $665,835	2,743 Added 215.98%	4,013 $946,000
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $433,731 - $575,246	-2,380 Reduced 65.21%	1,270 $257,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $690,616 - $887,680	3,650 New	3,650 $880,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.

Account

Argent Advisors, Inc. Amgen Inc Transaction History